NGL Fine-Chem Ltd. engages in the manufacture of pharmaceuticals and intermediates for usage in veterinary and human health. The firm's products include API animal and human health, intermediates, and finished dosage form. It operates through the following geographical segments: India, Europe, Asia Pacific, USA, and Rest of the World. The company was founded on December 18, 1981 and is headquartered in Mumbai, India.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company